tiprankstipranks
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Financial Statements

Compare
503 Followers

Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently $4.44M. The company's EPS TTM is $-3.475; its P/E ratio is ―; Adial Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -564.00$ -60.50K$ -55.11K$ -564.00
Operating Income$ -8.28M$ -6.89M$ -13.32M$ -19.29M$ -10.93M
EBITDA$ -8.28M$ -7.00M$ -13.32M$ -19.46M$ -10.93M
Net Income$ -13.20M$ -7.00M$ -12.73M$ -19.42M$ -10.86M
Balance Sheet
Cash & Short-Term Investments$ 3.75M$ 2.83M$ 4.00M$ 6.06M$ 4.40M
Total Assets$ 5.04M$ 4.74M$ 5.73M$ 7.47M$ 5.49M
Total Debt$ 0.00$ 0.00$ 207.38K$ 256.96K$ 0.00
Net Debt$ -3.75M$ -2.83M$ -3.79M$ -5.81M$ -4.40M
Total Liabilities$ 975.86K$ 653.08K$ 2.46M$ 3.97M$ 1.51M
Stockholders' Equity$ 4.07M$ 4.08M$ 3.28M$ 3.51M$ 3.99M
Cash Flow
Free Cash Flow$ -6.92M$ 0.00$ -11.19M$ -12.01M$ -7.63M
Operating Cash Flow$ -6.92M$ -6.81M$ -11.19M$ -11.95M$ -7.63M
Investing Cash Flow$ 0.00$ 1.50M$ 0.00$ -34.02K$ -350.00K
Financing Cash Flow$ 7.85M$ 4.13M$ 9.13M$ 13.64M$ 5.61M
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Adial Pharmaceuticals Debt to Assets

Adial Pharmaceuticals Cash Flow

Adial Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis